Prostate Cancer Reports
54

Volume 5 Issue 3
March 2017



Home > Prostate Cancer Reports > Volume 5, Year 2017 > Number 3, March


CONTENTS



CASE REPORTS
DIAGNOSIS AND EVALUATION
ETIOLOGY, PATHOGENESIS AND PATHOLOGY
FOLLOW-UP AND QUALITY OF LIFE
INTEGRATIVE MEDICINE
OVERALL MANAGEMENT
PROGNOSIS AND OUTCOMES
TREATMENT





CASE REPORTS



Groe Hokamp N, Kobe C, Linzenich E, Maintz D, Drzezga A.
Solitary PSMA-Positive Pulmonary Metastasis in Biochemical Relapse of Prostate Cancer.
Clin Nucl Med. 2017 Feb 13. doi: 10.1097/RLU.0000000000001582. [Epub ahead of print]
Source | Abstract | Full text | Similar articles




Sharif A, Malhotra NR, Acosta AM, Kajdacsy-Balla AA, Bosland M, Guzman G, Prins GS, Abern MR.
The Development of Prostate Adenocarcinoma in a Transgender Male to Female Patient: Could Estrogen Therapy Have Played a Role?
Prostate. 2017 Feb 13. doi: 10.1002/pros.23322. [Epub ahead of print]
Source | Abstract | Full text | Similar articles





DIAGNOSIS AND EVALUATION



Bjurlin MA, Rosenkrantz AB, Taneja SS.
Role of MRI prebiopsy in men at risk for prostate cancer: taking off the blindfold.
Curr Opin Urol. 2017 Feb 23. doi: 10.1097/MOU.0000000000000389. [Epub ahead of print]
Source | Abstract | Full text | Similar articles




Catalá V, Vilanova JC, Gaya JM, Algaba F, Martí T.
Multiparametric magnetic resonance imaging and prostate cancer: what's new?
Radiologia. 2017 Feb 21. pii: S0033-8338(17)30006-1. doi: 10.1016/j.rx.2016.12.003. [Epub ahead of print] English, Spanish.
Source | Abstract | Full text | Similar articles




Epstein JI, Amin MB, Reuter VE, Humphrey PA.
Contemporary Gleason Grading of Prostatic Carcinoma: An Update With Discussion on Practical Issues to Implement the 2014 International Society of Urological Pathology (ISUP) Consensus Conference on Gleason Grading of Prostatic Carcinoma.
Am J Surg Pathol. 2017 Feb 7. doi: 10.1097/PAS.0000000000000820. [Epub ahead of print]
Source | Abstract | Full text | Similar articles




Greer MD, Choyke PL, Turkbey B.
PI-RADSv2: How we do it.
J Magn Reson Imaging. 2017 Feb 25. doi: 10.1002/jmri.25645. [Epub ahead of print]
Source | Abstract | Full text | Similar articles




Jones TA, Marks LS.
Re: A Pilot Study to Evaluate the Role of Magnetic Resonance Imaging for Prostate Cancer Screening in the General Population.
Eur Urol. 2017 Feb 20. pii: S0302-2838(17)30101-X. doi: 10.1016/j.eururo.2017.02.012. [Epub ahead of print]
Comment on: Nam RK, Wallis CJ, et al, A Pilot Study to Evaluate the Role of Magnetic Resonance Imaging for Prostate Cancer Screening in the General Population.[ J Urol. 2016 Aug]
Source | Abstract | Full text | Similar articles




Meliti A, Sadimin E, Diolombi M, Khani F, Epstein JI.
Accuracy of Grading Gleason Score 7 Prostatic Adenocarcinoma on Needle Biopsy: Influence of Percent Pattern 4 and Other Histological Factors.
Prostate. 2017 Feb 3. doi: 10.1002/pros.23314. [Epub ahead of print]
Source | Abstract | Full text | Similar articles




Oliveira JM, Gomes C, Faria DB, Vieira TS, Silva FA, Vale J, Pimentel FL.
68Ga-prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography for Prostate Cancer Imaging: A Narrative Literature Review.
World J Nucl Med. 2017 Jan-Mar;16(1):3-7. doi: 10.4103/1450-1147.198237.
Source | Abstract | Full text | Similar articles




Robertson NL, Sala E, Benz M, Landa J, Scardino P, Scher HI, Hricak H, Vargas HA.
Combined whole-body and multi-parametric prostate MRI as a single-step approach for the simultaneous assessment of local recurrence and metastatic disease after radical prostatectomy.
J Urol. 2017 Feb 16. pii: S0022-5347(17)30292-6. doi: 10.1016/j.juro.2017.02.071. [Epub ahead of print]
Source | Abstract | Full text | Similar articles




Scott E.
Re: Raskolnikov D, George AK, et al., The role of magnetic resonance image guided prostate biopsy in stratifying men for risk of extracapsular extension at radical prostatectomy. J Urol. 2015 Jul;194(1):105-11. [Epub 2015 Jan 23]. doi: 10.1016/j.juro.2015.01.072
Urol Oncol. 2017 Mar;35(3):121. doi: 10.1016/j.urolonc.2016.12.013. Epub 2017 Feb 1.
Source | Abstract | Full text | Similar articles




Uprimny C, Kroiss AS, Decristoforo C, Fritz J, von Guggenberg E, Kendler D, Scarpa L, di Santo G, Roig LG, Maffey-Steffan J, Horninger W, Virgolini IJ.
68Ga-PSMA-11 PET/CT in primary staging of prostate cancer: PSA and Gleason score predict the intensity of tracer accumulation in the primary tumour.
Eur J Nucl Med Mol Imaging. 2017 Jan 31. doi: 10.1007/s00259-017-3631-6. [Epub ahead of print]
Source | Abstract | Full text | Similar articles




Wang R, Wang J, Gao G, Hu J, Jiang Y, Zhao Z, Zhang X, Zhang YD, Wang X.
Pre-biopsy mp-MRI can help to improve the predictive performance in prostate cancer: a prospective study in 1478 consecutive patients.
Clin Cancer Res. 2017 Jan 31. pii: clincanres.2884.2016. doi: 10.1158/1078-0432.CCR-16-2884. [Epub ahead of print]
Source | Abstract | Full text | Similar articles





ETIOLOGY, PATHOGENESIS AND PATHOLOGY



Gilani S, Guo CC, Li-Ning EM, Pettaway C, Troncoso P.
Transformation of prostatic adenocarcinoma to well differentiated neuroendocrine tumor after hormonal treatment.
Hum Pathol. 2017 Jan 31. pii: S0046-8177(17)30027-8. doi: 10.1016/j.humpath.2017.01.006. [Epub ahead of print]
Source | Abstract | Full text | Similar articles




Nakazawa M, Paller C, Kyprianou N.
Mechanisms of Therapeutic Resistance in Prostate Cancer.
Curr Oncol Rep. 2017 Feb;19(2):13. doi: 10.1007/s11912-017-0568-7. Epub 2017 Feb 22.
Source | Abstract | Full text | Similar articles





FOLLOW-UP AND QUALITY OF LIFE



Venderbos LD, Aluwini S, Roobol MJ, Bokhorst LP, Oomens EH, Bangma CH, Korfage IJ.
Long-term follow-up after active surveillance or curative treatment: quality-of-life outcomes of men with low-risk prostate cancer.
Qual Life Res. 2017 Feb 6. doi: 10.1007/s11136-017-1507-7. [Epub ahead of print]
Source | Abstract | Full text | Similar articles





INTEGRATIVE MEDICINE



Downer MK, Allard CB, Preston MA, Gaziano JM, Stampfer MJ, Mucci LA, Batista JL.
Regular Aspirin Use and the Risk of Lethal Prostate Cancer in the Physicians' Health Study.
Eur Urol. 2017 Feb 9. pii: S0302-2838(17)30069-6. doi: 10.1016/j.eururo.2017.01.044. [Epub ahead of print]
Source | Abstract | Full text | Similar articles




Downer MK, Batista JL, Mucci LA, Stampfer MJ, Epstein MM, Håkansson N, Wolk A, Johansson JE, Andrén O, Fall K, Andersson SO.
Dairy intake in relation to prostate cancer survival.
Int J Cancer. 2017 Feb 10. doi: 10.1002/ijc.30642. [Epub ahead of print]
Source | Abstract | Full text | Similar articles




Liu X, Li J, Schild SE, Schild MH, Wong W, Vora S, Herman MG, Fatyga M.
Statins and Metformin Use Is Associated with Lower PSA Levels in Prostate Cancer Patients Presenting for Radiation Therapy.
J Cancer Ther. 2017 Feb;8(2):73-85. doi: 10.4236/jct.2017.82007. Epub 2017 Feb 6.
Source | Abstract | Full text | Similar articles





OVERALL MANAGEMENT



Buyyounouski MK, Choyke PL, McKenney JK, Sartor O, Sandler HM, Amin MB, Kattan MW, Lin DW.
Prostate cancer - major changes in the American Joint Committee on Cancer eighth edition cancer staging manual.
CA Cancer J Clin. 2017 Feb 21. doi: 10.3322/caac.21391. [Epub ahead of print]
Source | Abstract | Full text | Similar articles




Haider MA, Yao X, Loblaw A, Finelli A.
Evidence-based guideline recommendations on multiparametric magnetic resonance imaging in the diagnosis of prostate cancer: A Cancer Care Ontario clinical practice guideline.
Can Urol Assoc J. 2017 Jan-Feb;11(1-2):E1-E7. doi: 10.5489/cuaj.3968.
Source | Abstract | Full text | Similar articles




PDQ Adult Treatment Editorial Board.
Prostate Cancer Treatment (PDQ®): Health Professional Version.
PDQ Cancer Information Summaries [Internet]. Bethesda (MD): National Cancer Institute (US). 2017 Jan 26.
Source | Abstract | Full text | Similar articles




PDQ Cancer Genetics Editorial Board.
Genetics of Prostate Cancer (PDQ®): Health Professional Version.
PDQ Cancer Information Summaries [Internet]. Bethesda (MD): National Cancer Institute (US). 2017 Feb 10.
Source | Abstract | Full text | Similar articles




PDQ Integrative, Alternative, and Complementary Therapies Editorial Board.
Prostate Cancer, Nutrition, and Dietary Supplements (PDQ®): Patient Version.
PDQ Cancer Information Summaries [Internet]. Bethesda (MD): National Cancer Institute (US), 2017 Feb 2.
Source | Abstract | Full text | Similar articles





PROGNOSIS AND OUTCOMES



Ashamalla H, Guirguis A, McCool K, McVorran S, Mattes M, Metzger D, Oromendia C, Ballman KV, Mokhtar B, Tchelebi M, Katsoulakis E, Rafla S.
Brachytherapy improves outcomes in young men (≤60 years) with prostate cancer: A SEER analysis.
Brachytherapy. 2017 Jan 27. pii: S1538-4721(16)30651-1. doi: 10.1016/j.brachy.2016.12.010. [Epub ahead of print]
Source | Abstract | Full text | Similar articles




Djaladat H, Amini E, Xu W, Cai J, Daneshmand S, Lieskovsky G.
Oncological Outcomes After Radical Prostatectomy for High-Risk Prostate Cancer Based on New Gleason Grouping System: A Validation Study From University of Southern California With 3,755 Cases.
Prostate. 2017 Feb 1. doi: 10.1002/pros.23306. [Epub ahead of print]
Source | Abstract | Full text | Similar articles




Furubayashi N, Negishi T, Iwai H, Nagase K, Taguchi K, Shimokawa M, Nakamura M.
Biochemical failure after radical prostatectomy in intermediate-risk group men increases with the number of risk factors.
Indian J Urol. 2017 Jan-Mar;33(1):64-69. doi: 10.4103/0970-1591.194786. Epub 2017 Jan 2.
Source | Abstract | Full text | Similar articles




Jackson WC, Desai NB, Abugharib AE, Tumati V, Dess RT, Lee JY, Zhao SG, Soliman M, Folkert M, Laine A, Hannan R, Zumsteg ZS, Sandler H, Hamstra DA, Montgomery JS, Miller DC, Kozminski MA, Hollenbeck BK, Hearn JW, Palapattu G, Tomlins SA, Mehra R, Morgan TM, Feng FY, Spratt DE.
Anatomical patterns of recurrence following biochemical relapse after post-prostatectomy salvage radiation therapy: a multi-institutional study.
BJU Int. 2017 Jan 31. doi: 10.1111/bju.13792. [Epub ahead of print]
Source | Abstract | Full text | Similar articles




Ozden C, Aktas BK, Bulut S, Erbay G, Tagci S, Gokkaya CS, Baykam MM, Memis A.
Effect of age on biochemical recurrence after radical prostatectomy.
Kaohsiung J Med Sci. 2017 Feb;33(2):91-95. doi: 10.1016/j.kjms.2016.11.002. Epub 2016 Dec 23.
Source | Abstract | Full text | Similar articles




Saeter T, Vlatkovic L, Waaler G, Servoll E, Nesland JM, Axcrona K, Axcrona U.
Intraductal Carcinoma of the Prostate on Diagnostic Needle Biopsy Predicts Prostate Cancer Mortality: A Population-Based Study.
Prostate. 2017 Feb 27. doi: 10.1002/pros.23326. [Epub ahead of print]
Source | Abstract | Full text | Similar articles




Wang L, Wang B, Ai Q, Zhang Y, Lv X, Li H, Ma X, Zhang X.
Long-term cancer control outcomes of robot-assisted radical prostatectomy for prostate cancer treatment: a meta-analysis.
Int Urol Nephrol. 2017 Feb 25. doi: 10.1007/s11255-017-1552-8. [Epub ahead of print]
Source | Abstract | Full text | Similar articles





TREATMENT



Bokhorst LP, Valdagni R, Rannikko A, Kakehi Y, Pickles T, Bangma CH, Roobol MJ; PRIAS study group.
A Decade of Active Surveillance in the PRIAS Study: An Update and Evaluation of the Criteria Used to Recommend a Switch to Active Treatment.
Eur Urol. 2016 Dec;70(6):954-960. doi: 10.1016/j.eururo.2016.06.007. Epub 2016 Jun 19.
Source | Abstract | Full text | Similar articles




D'Amico AV.
Active Surveillance Versus Treatment of Prostate Cancer: Should Metastasis Be the Primary End Point?
J Clin Oncol. 2017 Feb 27:JCO2016709527. doi: 10.1200/JCO.2016.70.9527. [Epub ahead of print]
Source | Abstract | Full text | Similar articles




Du C, Chen H, Li C.
Re: Alessandro Morlacco, John C. Cheville, Laureano J. Rangel, Derek J. Gearman, R. Jeffrey Karnes. Adverse Disease Features in Gleason Score 3 + 4 "Favorable Intermediate-risk" Prostate Cancer: Implications for Active Surveillance. Eur Urol. In press. http://dx.doi.org/10.1016/j.eururo.2016.08.043.
Eur Urol. 2017 Feb
3. pii: S0302-2838(17)30065-9. doi: 10.1016/j.eururo.2017.01.040. [Epub ahead of print]
Source | Abstract | Full text | Similar articles




Facchini G, Perri F, Misso G, D Aniello C, Scarpati GD, Rossetti S, Pepa CD, Pisconti S, Unteregger G, Cossu A, Caraglia M, Berretta M, Cavaliere C.
Optimal Management of Prostate Cancer Based on its Natural Clinical History.
Curr Cancer Drug Targets. 2017 Feb 8. doi: 10.2174/1568009617666170209093101. [Epub ahead of print]
Source | Abstract | Full text | Similar articles




Gandaglia G, Briganti A, Clarke N, Karnes RJ, Graefen M, Ost P, Zietman AL, Roach M 3rd.
Adjuvant and Salvage Radiotherapy after Radical Prostatectomy in Prostate Cancer Patients.
Eur Urol. 2017 Feb 9. pii: S0302-2838(17)30064-7. doi: 10.1016/j.eururo.2017.01.039. [Epub ahead of print]
Source | Abstract | Full text | Similar articles




Jereczek-Fossa BA, Fanetti G, Fodor C, Ciardo D, Santoro L, Francia CM, Muto M, Surgo A, Zerini D, Marvaso G, Timon G, Romanelli P, Rondi E, Comi S, Cattani F, Golino F, Mazza S, Matei DV, Ferro M, Musi G, Nolè F, de Cobelli O, Ost P, Orecchia R.
Salvage Stereotactic Body Radiotherapy for Isolated Lymph Node Recurrent Prostate Cancer: Single Institution Series of 94 Consecutive Patients and 124 Lymph Nodes.
Clin Genitourin Cancer. 2017 Jan 11. pii: S1558-7673(17)30004-6. doi: 10.1016/j.clgc.2017.01.004. [Epub ahead of print]
Source | Abstract | Full text | Similar articles




Llukani E, Lepor H.
Etiology and Management of Earlier versus Later Biochemical Recurrence Following Retropubic Radical Prostatectomy.
BJU Int. 2017 Feb 20. doi: 10.1111/bju.13816. [Epub ahead of print]
Source | Abstract | Full text | Similar articles




Masic S, Washington SL 3rd, Carroll PR.
Management of intermediate-risk prostate cancer with active surveillance: never or sometimes?
Curr Opin Urol. 2017 Feb 23. doi: 10.1097/MOU.0000000000000387. [Epub ahead of print]
Source | Abstract | Full text | Similar articles




Miñana López B.
Chemotherapy should not yet be considered in patients with hormono-sensitive metastatic prostate cáncer.
Actas Urol Esp. 2017 Feb 14. pii: S0210-4806(16)30206-6. doi: 10.1016/j.acuro.2016.11.008. [Epub ahead of print] English, Spanish.
Source | Abstract | Full text | Similar articles




Scott E.
Re: Sweeney CJ, Chen YH, et al, Chemohormonal therapy in metastatic hormone-sensitive prostate cancer. N Engl J Med. 2015 Aug 20;373(8):737-46. [Epub 2015 Aug 5]. doi: 10.1056/NEJMoa1503747
Urol Oncol. 2017 Mar;35(3):123. doi: 10.1016/j.urolonc.2016.12.021. Epub 2017 Feb 1.
Source | Abstract | Full text | Similar articles




Shipley WU, Seiferheld W, Lukka HR, Major PP, Heney NM, Grignon DJ, Sartor O, Patel MP, Bahary JP, Zietman AL, Pisansky TM, Zeitzer KL, Lawton CA, Feng FY, Lovett RD, Balogh AG, Souhami L, Rosenthal SA, Kerlin KJ, Dignam JJ, Pugh SL, Sandler HM; NRG Oncology RTOG
Comment in: Thompson IM Jr., Improved Therapy for PSA Recurrence after Prostatectomy. [N Engl J Med. 2017 Feb 2]
Radiation with or without Antiandrogen Therapy in Recurrent Prostate Cancer.
N Engl J Med. 2017 Feb 2;376(5):417-428. doi: 10.1056/NEJMoa1607529.
Source | Abstract | Full text | Similar articles




Syed JS, Javier-Desloges J, Tatzel S, Bhagat A, Nguyen KA, Hwang K, Kim S, Sprenkle PC.
Current Management Strategy for Active Surveillance in Prostate Cancer.
Curr Oncol Rep. 2017 Feb;19(2):11. doi: 10.1007/s11912-017-0569-6.
Source | Abstract | Full text | Similar articles




Thompson IM Jr.
Improved Therapy for PSA Recurrence after Prostatectomy.
Comment on: Shipley WU, Seiferheld W, et al, Radiation with or without Antiandrogen Therapy in Recurrent Prostate Cancer.[N Engl J Med. 2017 Feb 2]
N Engl J Med. 2017 Feb 2;376(5):484-485. doi: 10.1056/NEJMe1614133.
Source | Abstract | Full text | Similar articles




Wang C, King CR, Kamrava M, Iwamoto KS, Chen AM, Low D, Kupelian PA, Steinberg ML.
Pattern of solid and hematopoietic second malignancy after local therapy for prostate cancer.
Radiother Oncol. 2017 Feb 7. pii: S0167-8140(17)30031-2. doi: 10.1016/j.radonc.2017.01.009. [Epub ahead of print]
Source | Abstract | Full text | Similar articles